Is PEGylated G-CSF superior to G-CSF in patients with breast cancer receiving chemotherapy? A systematic review and meta-analysis

被引:0
|
作者
Xiang Li
Huan Zheng
Man-Cheng Yu
Wei Wang
Xin-Hong Wu
Dong-Mei Yang
Juan Xu
机构
[1] Huazhong University of Science and Technology,Department of Breast Surgery, Hubei Cancer Hospital, Tongji Medical College
[2] Wuchang Hospital Affiliated to Wuhan University of Science and Technology,Department of Neurology
来源
Supportive Care in Cancer | 2020年 / 28卷
关键词
PEGylated G-CSF; G-CSF; Breast cancer; Chemotherapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:5085 / 5097
页数:12
相关论文
共 50 条
  • [31] SERUM G-CSF LEVELS IN PATIENTS UNDERGOING G-CSF CHEMOTHERAPY MOBILIZED PERIPHERAL STEM-CELL HARVEST
    MAHARAJ, D
    LEWISXIMENEZ, L
    RILEY, R
    ALBARRACION, C
    GOMEZ, O
    ONEILL, JG
    BLOOD, 1994, 84 (10) : A349 - A349
  • [32] Retrospective Comparison of Neutropenia in Children With Ewing Sarcoma Treated With Chemotherapy and Granulocyte Colony-Stimulating Factor (G-CSF) or Pegylated G-CSF
    Milano-Bausset, Emilie
    Gaudart, Jean
    Rome, Angelique
    Coze, Carole
    Gentet, Jean Claude
    Padovani, Laetitia
    Lacarelle, Bruno
    Andre, Nicolas
    CLINICAL THERAPEUTICS, 2009, 31 : 2388 - 2395
  • [33] Neutrophils, G-CSF and their contribution to breast cancer metastasis
    Mouchemore, Kellie A.
    Anderson, Robin L.
    Hamilton, John A.
    FEBS JOURNAL, 2018, 285 (04) : 665 - 679
  • [34] Kinetics of autologous stem cell mobilization failure: Comparison of AMD3100/G-CSF, G-CSF, GM-IG-CSF, and chemotherapy/g-csf on remobilization success
    DiPersio, J. F.
    Smith, A.
    Sempek, D.
    Baker, A.
    Jiang, S.
    Vij, P.
    Cashen, A.
    Westervelt, P.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) : 8 - 8
  • [35] G-CSF could worsen anaemia in breast cancer
    Furlow, Bryant
    LANCET ONCOLOGY, 2006, 7 (08): : 622 - 622
  • [36] The value of G-CSF in women experienced at least one implantation failure: a systematic review and meta-analysis
    Su, Qing
    Pan, Zhuo
    Yin, Rong
    Li, Xuemei
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [37] G-CSF for the prophylaxis of neutropenic fever in patients with small cell lung cancer receiving myelosuppressive antineoplastic chemotherapy: Meta-analysis and pharmacoeconomic evaluation
    Messori, A
    Trippoli, S
    Tendi, E
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 1996, 21 (02) : 57 - 63
  • [38] Primary or secondary G-CSF prophylaxis to support TAC chemotherapy in breast cancer?
    Hupperets, P. S.
    Tjan-Heijnen, V. C.
    ANNALS OF ONCOLOGY, 2006, 17 (08) : 1181 - 1183
  • [39] G-CSF PRODUCING LUNG CANCER
    Matsuda, E.
    Okabe, K.
    Yamamoto, H.
    Tao, H.
    Kobayashi, S.
    Hirazawa, K.
    Sugi, K.
    LUNG CANCER, 2011, 71 : S32 - S32
  • [40] Effectiveness and safety of primary prophylaxis of G-CSF during chemotherapy for prostate cancer, Japanese clinical guideline for appropriate use of G-CSF: clinical practice guidelines for the use of G-CSF 2022
    Shoji Kimura
    Keisuke Shigeta
    Shingo Tamura
    Keita Uchino
    Takahiro Kimura
    Yukinori Ozaki
    Hiroshi Nishio
    Kenji Tsuchihashi
    Eiki Ichihara
    Makoto Endo
    Shingo Yano
    Dai Maruyama
    Tetsuhiro Yoshinami
    Nobuyuki Susumu
    Munetaka Takekuma
    Takashi Motohashi
    Mamoru Ito
    Eishi Baba
    Nobuaki Ochi
    Toshio Kubo
    Yutaro Kamiyama
    Shinji Nakao
    Shinobu Tamura
    Hitomi Nishimoto
    Yasuhisa Kato
    Atsushi Sato
    Toshimi Takano
    Yuji Miura
    International Journal of Clinical Oncology, 2024, 29 : 559 - 563